OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase 1 Testing of Anti-Cancer Stem Cell Therapeutic OMP …
OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase 1 Testing of Anti-Cancer Stem Cell Therapeutic OMP …
REDWOOD CITY, Calif., April 28, 2011 /PRNewswire/ — OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells or tumor-initiating cells, today announced that the FDA has accepted an IND filing for OMP-18R5, which allows OncoMed to commence Phase 1 clinical testing. OMP-18R5 is a monoclonal antibody that binds selected receptors in the Wnt signaling …
Read more on redOrbit
Categories: Breast Cancer Information Tags: Announces, Anticancer, Cell, Clearance, Commence, OncoMed, Pharmaceuticals, Phase, Stem, testing, Therapeutic
Vical receives EMA Scientific Advice for Phase 3 trial of TransVax therapeutic CMV vaccine
Vical receives EMA Scientific Advice for Phase 3 trial of TransVax therapeutic CMV vaccine
Vical Incorporated announced today the receipt of Scientific Advice from the European Medicines Agency (EMA) recommending practical efficacy endpoints for a Phase 3 trial of the company’s TransVax™ therapeutic cytomegalovirus (CMV) vaccine.
Read more on News-Medical-Net
Categories: Breast Cancer Awareness Tags: advice, Phase, receives, Scientific, Therapeutic, TransVax, Trial, vaccine, Vical
Chemo Brain & Recovery [Part 14 of 17]: Therapeutic Value of Physical and Mental Exercise
Stage III breast cancer survivor Dr. Susan Hardwicke explains how physical exercise helps create new brain cells, and repeated mental exercises help create new brain structure. Workshop was addressed to cancer survivors and oncology nurses at the Leukemia and Lymphoma Society’s Blood Cancer Conference in Virginia.
Categories: Breast Cancer Survivors Tags: brain, chemo, Exercise, mental, part, Physical, recovery, Therapeutic, Value
Xoft Awarded Two Qualifying Therapeutic Discovery Project Program Grants For Electronic Brachytherapy
Xoft Awarded Two Qualifying Therapeutic Discovery Project Program Grants For Electronic Brachytherapy
Xoft, Inc., developer of the Axxent® Electronic Brachytherapy, eBx⢠System, announced today that it has received nearly $500,000 in grants from the Qualifying Therapeutic Discovery Project Program.  Xoft received the maximum amount of $244,479.25 for two Electronic Brachytherapy grants, one for the treatment of breast cancer and one for the treatment of gynecological cancers.  The …
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Treatment Tags: awarded, Brachytherapy, Discovery, Electronic, Grants, program, Project, Qualifying, Therapeutic, XOFT
Potential therapeutic target across a range of cancer types found
Potential therapeutic target across a range of cancer types found
London, Oct 21 : Researchers have found a common link among several malignant tumor types in all grades of cancer.
Read more on New Kerala
Categories: Breast Cancer Tumor Tags: Across, cancer, Found, Potential, Range, target, Therapeutic, Types